Janney Montgomery Scott LLC Amneal Pharmaceuticals, Inc. Transaction History
Janney Montgomery Scott LLC
- $38.3 Billion
- Q2 2025
A detailed history of Janney Montgomery Scott LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 23,150 shares of AMRX stock, worth $208,813. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,150
Previous 19,350
19.64%
Holding current value
$208,813
Previous $162,000
15.43%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AMRX
# of Institutions
251Shares Held
136MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA17.6MShares$158 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$111 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$102 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$96.8 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$67.6 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.37B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...